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INTRODUCTION
Over a dozen immunological deficiency diseases with associated hypogammaglobulinemia have been described.
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A reduction in the serum concentration of one or more of the immunoglobulin classes may occur secondary to a variety of pathophysiological mechanisms that affect the rates of synthesis, the distribution, or the rates of catabolism or loss of these proteins (1) . Hypogammaglobulinemia may result from decreased synthesis of all major classes of immunoglobulins (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Alternatively, a defect in immunoglobulin synthesis may be restricted to one or two classes of immunoglobulins, as in patients with ataxia telangiectasia (14) or the other dysgammaglobulinemias (12, 15) . A second major pathophysiological mechanism resulting in hypogammaglobulinemia is excessive loss of serum proteins into the urinary, respiratory, or gastrointestinal tracts (7, (16) (17) (18) . A third major mechanism resulting in hypogammaglobulinemia is hypercatabolism of immunoglobulins. This hypercatabolism may involve different classes of serum proteins, as in the recently reported syndrome of familial hypercatabolic hypoproteinemia (19) . Alternatively, the hypercatabolism may be restricted to a single class of proteins as in the isolated hypercatabolism of IgG in patients with myotonic dystrophy (20) . The cause of the hypercatabolism of serum proteins in these disorders has not been defined.
We now report on another cause of hypogammaglobulinemia with reduced immunoglobulin survival. The hypogammaglobulinemia, affecting three subclasses of IgG, (Gi, G2, and G4) is associated with an abnormal immunoglobulin-immunoglobulin interaction. The patient studied has Sj6gren's syndrome with a mixed (IgMIgG) cryoglobulinemia and a high serum level of a monoclonal IgG-reactive IgM, a slightly elevated concentration of IgG3, and a markedly reduced concentration of the other IgG subclasses. The patient's IgM forms complexes with IgGi, IgG2, and IgG4 subclasses over a range of temperatures attainable in vivo. The rate of synthesis of these IgG subclasses is markedly depressed. The survival of these subclasses is shortened in the patient presumably due to the formation in vivo of IgM-IgG complexes which are rapidly catabolized. IgG3 subclass molecules do not complex with the patient's IgM at body temperature and have a normal survival and synthetic rate.
METHODS
Patient. The patient, D. K., is a 73 yr old white woman with the diagnosis of Sj6gren's syndrome who presented with an 8 yr history of recurrent fever, usually associated with cold exposure, and a 5 yr history of recurrent parotitis with saccular parotid sialectasis, dacryocystitis, otitis media, and anemia. Her clinical findings have been published (21) . Lobectomy for a cavitary right upper lobe lesion revealed an infiltrate of plasma cells and small lymphocytes consistent with the diagnosis of pseudolymphoma (21) . Additional features of her illness are a rheumatoid factor titer by bentonite flocculation test of > 1:8192, depressed total serum hemolytic complement, elevated serum IgM, depressed IgG, and a striking mixed cryogelglobulinemia consisting of IgM and IgG. Five attempts to immunize her with typhoid antigen and two attempts with Foshay tularemia and Escherichia coli Vi antigens were unsuccessful. She was successfully sensitized to dinitrochlorobenzene.
Isolation and characterization of the components of the patient's cryogel. The mixed cryogel was isolated by chilling the patient's citrated plasma to 40C in an ice bath. It was freed of other serum proteins by repeatedly dissolving it in pH 7.0, 0.01 M sodium phosphate buffer made 0.05 M in NaNs at 401C followed by regelling at 40C.
The two components of the cryogel were purified by first redissolving the gel in 1.0 M KSCN followed by ultracentrifugation at 40'C. The IgM component was isolated from the pelleted material by DEAE-cellulose chromatography at 40°C. The IgG component was obtained from the supernatant of the ultracentrifugation by DEAE-cellulose chromatography.
Analytical ultracentrifugation of the purified cryogel or its subunits was performed at various temperatures in the Spinco Model E ultracentrifuge (Beckman Spinco, Palo Alto, Calif.) at 56,100 rpm. The association of the purified IgMDK from the patient's cryogel with an IgGl myeloma protein or an IgG3 myeloma protein was studied at rotor temperatures from 250 to 40'C as described by Stone and Metzger (22) .
The components of the cryogel were identified by immunoelectrophoresis and double diffusion methods using sheep antisera to human immunoglobulin heavy chains and to human K and X-light chains.
Analytical polyacrylamide disc gel electrophoresis of the light chains obtained from IgGDK and IgMDK was performed using a 7% monomer polyacrylamide gel in 10 M urea according to the method of Reisfeld and Small (23) .
Specificity of the interaction between IgMDK
and serum proteins D. K. serum (1.0 ml) was mixed with l'I-labeled serum proteins at 40'C, incubated for 10 min, then cooled in an ice bath before centrifugation at 3000 rpm at 4°C. The supernatant was removed and discarded and 5 ml of 0.15 M saline was added to the cryogel. The cryogel was then warmed to 40'C to bring it into solution. This process was repeated five times. The radioactivity remaining in the gel was then determined in a well-type gamma ray scintillation counter (Nuclear-Chicago Corp., Des Plaines, Ill.). Additional studies were performed to determine which purified proteins would cause purified IgMDK to gel. In these studies 0.1 mg of IgMDK radiolabeled with 'I was incubated with various proteins at a molar ratio of 7: 1 (protein to IgMDK). The reactants were incubated in 0.3 ml of pH 7.0, 0.01 sodium phosphate, 0.1 M sodium chloride buffer at room temperature for 1 hr, refrigerated at 4'C overnight, and then centrifuged at 2000 rpm at 40C for 1 hr. The radioactivity retained in the precipitate was then determined.
Viscosity measurements. Viscosity measurements employed an Ostwald capillary viscosimeter with a water freefall time of 39.0 sec at 500 C. Temperature control was maintained at +0.2'C in a water bath monitored by a precision total immersion thermometer (Fisher Scientific Co., Pittsburg, Pa.).
Quantitation of immunoglobulins. Immunoglobulin concentrations were determined by the radial diffusion method of Mancini, Carbonara, and Heremans (24) at 400C using Hyland Immunoplates (Hyland Div., Travenol Labs, Inc., Costa Mesa, Calif.). IgG concentrations were also determined in the presence of 0.001 M dithiothreitol with results agreeing closely with those determined at 400C in the absence of a reducing agent. IgG3 levels were determined by a solid phase radioimmunoassay described by Mann, Granger, and Fahey (25) . The sum of IgG1, 2, and 4 levels were determined from the difference between the total IgG level and the IgG3 level.
Preparation of labeled proteins for turnover study. The preparation of IgG, IgA, IgM, IgG3, and albumin for labeling was performed by techniques that have been described previously (8, 9, 14, 26) . IgE was obtained from the serum of a patient with an IgE myeloma protein by DEAE-cellulose chromatography. Albumin was prepared from normal serum by Geon' and Pevikon' block electrophoresis. Each of the preparations was analyzed by radioimmunoelectrophoresis and Ouchterlony double diffusion, using antisera to whole human serum, albumin, IgG, IgA, IgM, and transferrin. All of the preparations were found to be free of contaminating proteins using these techniques.
Iodination of the above proteins was performed with either 'I or 'I by the iodine monochloride technique of McFarlane (27) . All preparations were calculated to have an average of less than one atom of iodine per molecule of protein in the final product. The products contained less than 1%o nonprecipitable radioactivity.
Study protocol. Each of the radiolabeled serum proteins was administered to the patient and to at least three control subjects who had diseases not affecting serum protein metabolism. From 10 to 50 ,uCi of the iodinated proteins were administered intravenously from a calibrated syringe and serum samples were obtained 10 min after administration and daily thereafter. Urine specimens were collected in 24-hr lots. Serum and urine samples were counted with appropriate standards to within ±3%o counting error in an automatic gamma ray scintillation counter. Calculation of the data. The time course of decline of radioactivity from the serum and whole body was plotted semilogarithmically. These curves were used to determine 1Geon Resin, B. F. Goodrich Co., Niagara Falls, N. Y.
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the plasma volume, total circulating protein pool, total exchangeable protein pool, fraction of the circulating pool catabolized per day, the survival ti and the synthetic rate of the protein, according to the method of Nosslin (28) .
RESULTS
Characterization of the gel. The purified cryogel isolated from the plasma of D. K. examined by analytical ultracentrifugation at 40°C in pH 8.6 tris-HCL buffer was shown to contain two major sedimenting components, one with a sedimentation constant of 7S and the other of 18S. The 7S component was identified immunologically as IgG (IgGDK) and shown to be composed of electrophoretically heterogeneous molecules containing both K-and X-light polypeptide chains. The purified 18S component was identified as IgM (IgMDK), and in contrast to the IgG component was demonstrated to be antigenically homogeneous with respect to light polypeptide chains containing only X-antigenic determinants. The light polypeptide chains prepared from IgMDK when examined by alkaline urea polyacrylamide disc gel electrophoresis were of highly restricted mobility analogous to those of a Waldenstrom's macroglobulin, However, the light chains from IgGDK were electrophoretically heterogenous. Thus, the IgM component of the mixed cryogel had the characteristics of a monoclonal protein while the IgG was comparable to normal heterogeneous IgG.
Specificity of the interaction of IgMDK with IgG and IgG subunits
Neither the isolated IgGDK nor the isolated IgMDK would form a cryogel in vitro in the pH 7 and ionic strength solvent conditions studied. The IgMDK would, however, form a cryogel if normal serum or normal IgG was incubated with it. The IgGDK would neither form a cryogel under these circumstances nor if incubated with other purified IgM proteins. It was thus felt that the cryogel of patient D. K. formed as a result of the interaction of the patient's abnormal monoclonal IgM protein with normal IgG.
The ability of IgMDK cryogels to trap serum proteins in the gel was studied by adding radioiodine labeled purified serum proteins to D. K. serum as described in methods. No significant quantities of added radiolabeled albumin, ceruloplasmin, IgA, IgD, IgE, normal IgM, or X-or K Bence Jones proteins were associated with the cryogel after five washings. In contrast, 50-85% of normal IgG and of myeloma IgG of the GI, G2, and G4 subclasses remained associated with the gel after five washings (Table I) . Significantly lower quantities (3%) of three different IgG3 myeloma proteins were associated with the gel following this procedure. Low but significant quantities (3-7%) of mouse IgG, rabbit IgG, and canine IgG were trapped by the D. K. cryogel. In an attempt to study complex formation in the presence of other serum proteins, the viscosity characteristics of fresh whole plasma D. K. were examined over a wide temperature range. The data plotted in Fig.  2 show a change in viscosity behavior at approximately 370C as manifested by a change in slope to one of greater negativity. 8 Protein turnover studies. The results of the radioiodinated albumin, IgA, IgM, and IgE turnover studies are shown in Table III . Patient D. K. had a somewhat reduced serum protein concentration, total circulating protein pool, and total body pool of albumin, IgA, and IgE. In each case, the synthetic rate of these proteins was reduced to between 46 and 70% of normal. The half-time of survival and the fractional catabolic rate of these proteins, however, were within the normal range. The serum concentration, total circulating and total body pools of IgM and the rate of synthesis of IgM were markedly increased as assessed in studies using normal IgM or IgM isolated from patient D. K. The half-time of survival and the fractional catabolic rate of normal IgM were normal in the patient. The IgM of patient D. K. showed a catabolic rate comparable to normal IgM after the first 24 hr when slightly accelerated catabolism was observed.
The different subclasses of IgG had quite different metabolic behavior in patient D. K. The survival of IgG isolated from normal serum' was studied in patient D. K. on three occasions (Table IV) ; at one time when she was on no therapy, a second time when she was receiving penicillamine 750 mg/day, and a third time immediately following penicillamine therapy. On each occasion, the serum concentration of the IgG subclasses other than G3, the total circulating IgG pool, and the total 'Validity of choosing two slopes between 29-530C to fit the data was tested by examining the scatter of points about the two slopes and comparing them to the scatter about a single regression line drawn through all the points. The two slopes depicted on the graph between 29-480C are significantly different (t = 7.54, 9 degrees of freedom, P < 0.001).
'Over 97%o of this material was GI, G2, and G4. body IgG pool were reduced to 10% of normal (Table   IV The metabolism of radioiodinated purified gamma globulin of the IgG3 subclass was studied in patient D. K. and controls. In patient D. K. the serum IgG3 concentration, total circulating and total body IgG3 pool sizes were increased (Table V) . The IgG3 synthetic rate was normal in contrast to the markedly reduced synthetic rates observed with the other IgG subclasses. The survival of IgG3 in normal recipients is much shorter than that of the other subclasses with a ti of survival of 7.1 days and a fractional catabolic rate of 16.8% of the intravascular pool per day. In patient D. K. however, the IgG3 survival tj was prolonged to 17 days and the fractional catabolic rate was reduced to 6.8% of the intravascular pool per day. This is the first report of a short survival of some subclasses of IgG with normal or prolonged survival of another subclass (IgG3).
DISCUSSION
The serum of D. K. contained a large amount of a mixed IgM-IgG cryogel. Recently a similar cryogel has been extensively studied and shown to probably represent the immune reaction of a homogeneous IgM antibody with IgG (22, 29) . In those studies the following criteria were proposed for an antibody: (a) The protein must be well characterized as a known immunoglobulin; (b) the "antibody" must have a clearly defined specificity; (c) the entire preparation of antibody must be active; (d) antigen should be bound by only those fragments of the antibody possessing the antigen-binding site-F(ab') 2t. and Fab /A in the present case; (e) the reaction between antibody and antigen should exhibit a stoichiometry consistent with the number of potential antigenbinding sites. An IgM antibody therefore should exhibit a valence of 10 (37) . In addition, the patient had none of the clinical features associated with the other syndromes (familial hypercatabolic hypoproteinemia (19) , the Wiskott-Aldrich syndrome (38) The metabolism of the IgG3 subclass in patient D. K. contrasts markedly with that of the other major subclasses. The IgG3 serum level and total circulating pool were elevated. The synthetic rate was normal while the survival ti was longer than normal. As noted previously the survival of IgG3 in normal recipients is much shorter than that of the other subclasses with a ti of survival of 7.5 days (26, 39) . In patient D. K. the survival ti was 17 days. IgG3 participates in the concentration-catabolism effect discussed above in which the expected IgG survival of any subclass is determined by the total IgG level (26) . The 17 day survival ti of IgG3 which does not form complexes with IgMDK at body temperature was that which would be predicted on the basis of the total IgG concentration of 2.6 mg/ml. These studies in patient D. K. are the first to demonstrate a pathological process that results in a significantly shortened survival of some subclasses of IgG while the survival of the remaining subclass is that expected on the basis of the IgG serum level. These findings are best explained by the fact that IgMDK reacts with the IgG 1, 2, 4 subclasses at body temperature to form rapidly catabolized complexes while IgMDK does not react with IgG3 to form such complexes at body temperature.
